A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro

Immunology

Volumn 113, Issue 2, 2004, Pages 253-259

  Andersson, Theresa N ^a,d   Ekman, Gunilla J ^a   Grönlund, Hans ^a   Buentke, Eva ^a,b   Eriksson, Tove L J ^a,c   Scheynius, Annika ^a   Van Hage Hamsten, Marianne ^a   Gafvelin, Guro ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c Affibody AB   (Sweden)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adjuvant; Allergen specific immunotherapy; Fel d 1; Microparticles; Monocyte derived dendritic cells

Indexed keywords

ADJUVANT; ALLERGEN; ALUMINUM HYDROXIDE; CARBOHYDRATE; CD86 ANTIGEN; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 8; RECOMBINANT FEL D 1 ALLERGEN; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CARBOHYDRATE BASED PARTICLE; CAT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FLOW CYTOMETRY; GRANULOMA; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOTHERAPY; IN VITRO STUDY; MATERIAL STATE; NORMAL HUMAN; PRIORITY JOURNAL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ALLERGENS; ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; ANTIGENS, SURFACE; CATS; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; INTERLEUKIN-8; MEMBRANE GLYCOPROTEINS; MICROSCOPY, CONFOCAL; RECOMBINANT PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 4744355000     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.01943.x     Document Type: Article

References (41)

1. Johansson SG, Hourihane JO, Bousquet J et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56:813-24.
2. Kay AB. Allergy and Allergic Diseases. Oxford: Blackwell Science, 1997.
3. Durham SR, Till SJ. Immunologic changes associated with allergen immunotherapy. J Allergy Clin Immunol 1998; 102:157-64.
4. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102:558-62.
5. Cox JC, Coulter AR. Adjuvants - a classification and review of their modes of action. Vaccine 1997; 15:248-56.
6. Gherardi RK, Coquet M, Cherin P et al. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. Brain 2001; 124:1821-31.
7. Gronlund H, Vrtala S, Wiedermann U, Dekan G, Kraft D, Valenta R, Van Hage-Hamsten M. Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy. Immunology 2002; 107:523-9.
8. Osterballe O. Side effects during immunotherapy with purified grass pollen extracts. Allergy 1982; 37:553-62.
9. Vogelbruch M, Nuss B, Korner M, Kapp A, Kiehl P, Bohm W. Aluminium-induced granulomas after inaccurate intradermal hyposensitization injections of aluminium-adsorbed depot preparations. Allergy 2000; 55:883-7.
10. Brewer JM, Conacher M, Hunter CA, Mohrs M, Brombacher F, Alexander J. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol 1999; 163:6448-54.
11. Valenta R. The future of antigen-specific immunotherapy of allergy. Nat Rev Immunol 2002; 2:446-53.
12. Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci USA 1993; 90:4942-6.
13. Steinman RM. Some interfaces of dendritic cell biology. Apmis 2003; 111:675-97.
14. Sallusto F, Lanzavecchia A. The instructive role of dendritic cells on T-cell responses. Arthritis Res 2002; 4 (Suppl. 3):S127-32.
15. Herrick CA, Bottomly K. To respond or not to respond: T cells in allergic asthma. Nat Rev Immunol 2003; 3:405-12.
16. Gronlund H, Bergman T, Sandstrom K et al. Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J Biol Chem 2003; 278:40144-51.
17. Axen R, Porath J, Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature 1967; 214:1302-4.
18. + dendritic cells. Clin Exp Allergy 2000; 30:1759-70.
19. Romani N, Gruner S, Brang D et al. Proliferating dendritic cell progenitors in human blood. J Exp Med 1994; 180:83-93.
20. Buentke E, Heffler LC, Wallin RP, Lofman C, Ljunggren HG, Scheynius A. The allergenic yeast Malassezia furfur induces maturation of human dendritic cells. Clin Exp Allergy 2001; 31:1583-93.
21. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9:10-6.
22. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-52.
23. Siegel S, Castellan NJ. Nonparametric Statistics for the Behavioral Sciences, 2nd edn. New York: McGraw-Hill, 1988.
24. Witsch EJ, Peiser M, Hutloff A, Buchner K, Dorner BG, Jonuleit H, Mages HW, Kroczek RA. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells. Eur J Immunol 2002; 32:2680-6.
25. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182:389-400.
26. Noirey N, Rougier N, Andre C, Schmitt D, Vincent C. Langerhans'-like dendritic cells generated from cord blood progenitors internalize pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naive T lymphocytes. J Allergy Clin Immunol 2000; 105:1194-201.
27. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996; 14:233-58.
28. Larche M, Till SJ, Haselden BM, North J, Barkans J, Corrigan CJ, Kay AB, Robinson DS. Costimulation through CD86 is involved in airway antigen-presenting cell and T cell responses to allergen in atopic asthmatics. J Immunol 1998; 161:6375-82.
29. Hammad H, Charbonnier AS, Duez C, Jacquet A, Stewart GA, Tonnel AB, Pestel J. Th2 polarization by Der p 1-pulsed monocyte-derived dendritic cells is due to the allergic status of the donors. Blood 2001; 98:1135-41.
30. Straw AD, MacDonald AS, Denkers EY, Pearce EJ. CD154 plays a central role in regulating dendritic cell activation during infections that induce Th1 or Th2 responses. J Immunol 2003; 170:727-34.
31. Sansom DM, Manzotti CN, Zheng Y. What's the difference between CD80 and CD86? Trends Immunol 2003; 24:314-9.
32. Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? Trends Immunol 2002; 23:445-9.
33. Bohle B. CpG motifs as possible adjuvants for the treatment of allergic diseases. Int Arch Allergy Immunol 2002; 129:198-203.
34. Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan - DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5:387-91.
35. Mothes N, Heinzkill M, Drachenberg KJ et al. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 2003; 33:1198-208.
36. Lewis DB. Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? Curr Opin Immunol 2002; 14:644-51.
37. Hansen G, Berry G, DeKruyff RH, Umetsu DT. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J Clin Invest 1999; 103:175-83.
38. Dahl ME, Dabbagh K, Liggitt D, Kim S, Lewis DB. Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5:337-43.
39. Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R. Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet 2001; 357:752-6.
40. Hamilton JA, Byrne R, Whitty G. Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1. J Leukoc Biol 2000; 67:226-32.
41. Yang X, Gieni RS, Mosmann TR, HayGlass KT. Chemically modified antigen preferentially elicits induction of Th1-like cytokine synthesis patterns in vivo. J Exp Med 1993; 178:349-53.